Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer.
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer.
Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15.
The Oncology QCARD Initiative: Fostering efficient evaluation of initial real-world data proposals.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer.
Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer. JAMA Netw Open. 2024 Mar 04; 7(3):e243345.
View in:
PubMed
subject areas
Aged
Breast Neoplasms
Cohort Studies
Female
Hormones
Humans
Lymphocytes, Tumor-Infiltrating
Middle Aged
Prospective Studies
Receptor, ErbB-2
authors with profiles
Marilyn L. Kwan, PhD
Lawrence H. Kushi, ScD